Penningtons Manches Cooper advises Titian Software on majority investment from Battery Ventures

Posted: 12/07/2022

The corporate team at Penningtons Manches Cooper has advised shareholders of Titian Software, a leading sample management software solution provider to the life sciences sector, on the significant, majority investment from Battery Ventures, a US technology-focused investment firm. Titian will use the new funds to support organic growth as well as potential future acquisitions.

Titian’s Mosaic product is the leading sample management software for life science laboratories. Mosaic helps researchers better manage and automate critical processes, allowing its customers to maximise research efficiency and speed up the discovery and delivery of new drugs.

Founded in 1983, Battery Ventures backs companies at all stages, ranging from seed and early to growth and buyout, and invests globally from six strategic locations: Boston; San Francisco, California, Tel Aviv, London, and New York.

Edmund Wilson, Chief Executive Officer and Founder of Titian Software, comments:

“Our new partnership with Battery represents a key inflection point for the company that should allow us to scale even further. With Battery’s help, Titian can better capitalise on the exciting growth opportunities we see ahead in the sample-management sector. I’d like to thank Will Axtell and the team at Penningtons Manches Cooper for their expertise and advice on this strategic deal.”

The corporate team advising Titian Software was led by partner Will Axtell and senior associate Dominique Sabatini with support from associate Lindsay Chadwick. The wider team included support from corporate tax associate Leonie Langley, pensions partner Alison Hills and senior associate Clare Coley, commercial managing associate Edmund Forey and senior associate Susie Hilton Knox, real estate senior associate Giorgia Clements and employment associate Hannah Grayson.

Will Axtell said:

“We are delighted to have advised the team at Titian Software on this important cross-border technology transaction. This demonstrates the strength of our life sciences and technology teams as well as our ability to transact complex and large cross-border corporate deals effectively and at pace. We wish Titian all the best for their exciting future with Battery Ventures.”

Return to news headlines